Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results
Date:11/15/2009

estions.

    To access the conference call, please dial:

    United States toll-free dial-in number:   +1 800 706 7741
    International dial-in number:             +1 617 614 3471
    North China toll-free dial-in number:     +86 10 800 152 1490
    South China toll-free dial-in number:     +86 10 800 130 0399
    China toll free / Netcom:                 +86 10 800 852 1490
    Hong Kong dial-in number:                 +852 3002 1672

Please ask to be connected to Simcere's Q3 2009 earnings call and provide the following passcode: 32750293. Simcere will also broadcast a live audio webcast of the conference call. The broadcast will be available by visiting the "Investor Relations" section of the Company's web site at http://www.simcere.com .

Following the earnings conference call, an archive of the call will be available by dialing:

United States toll-free dial-in number: +1 888 286 8010

    United States dial-in number:              +1 617 801 6888

The passcode for replay participants is: 77133325. The telephone replay also will be archived on the "Investor Relations" section of the Company's web site for seven days following the earnings announcement.

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (SCR, Simcere) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China. In recent years, Simcere has been focusing its strategy on the development of innovative pharmaceuticals and first-to-market generics, and has introduced an innovative anti-cancer medication Endu, a first-to-market medication Sinofuan, and first-to-market generics such as Bicun and Anxin. Simcere manufactures and sells antibiotics, anti-cancer medication stroke management medication and biopharmaceutical
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
2. Simcere Pharmaceutical Group Invested Company Obtains Production License for H1N1 Flu Vaccine
3. Simcere Announces Strategic Partnership with Sun Yat-Sen University Cancer Center
4. Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share Repurchase
5. Simcere Pharmaceutical Group to Announce 2009 Second Quarter Earnings on Monday, August 17, 2009
6. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
7. Simcere Pharmaceutical Group Seeking Approval to Manufacture and Sell Influenza Drug zanamivir
8. Simcere Pharmaceutical Group to Participate in Goldman Sachs China Investment Frontier Conference 2008
9. Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
10. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
11. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- Anyone who ... something about feet that fungi seem to like. But ... fungal groups that live on your skin -- and, ... It,s no secret that the human body is awash ... both outside and inside. And it,s mainly a friendly ...
(Date:5/22/2013)... New York, New York (PRWEB) May 22, 2013 ... a metal-on-metal version of the DePuy Pinnacle Hip Replacement ... underway in Texas Federal Court, Bernstein Liebhard LLP reports. ... Court has directed DePuy Orthopaedics to produce monitoring reports ... government into the company’s medical device marketing practices. ...
(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...
(Date:5/22/2013)... researchers report that hospitals may be reaping enormous ... by preventable bloodstream infections contracted in their intensive ... reported online in the American Journal of ... ICU patient who develops an avoidable central line-associated ... to care for than a similar infection-free patient. ...
(Date:5/22/2013)... Registered Dietitian and Founder of Tatalou Science ... sharing a recipe for making energy bars at home. , ... ,” takes a recipe modified from one recently featured ... day it gets more and more difficult to understand what ... size of the nutrition label continues to grow and consumers ...
Breaking Medicine News(10 mins):Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes New Order in Federal Pinnacle Litigation Requiring Production of Monitoring Reports from Federal Investigation 3Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Hospitals profit when patients develop bloodstream infections 2Health News:Hospitals profit when patients develop bloodstream infections 3Health News:Hospitals profit when patients develop bloodstream infections 4Health News:How To "Make Your Own Healthy Energy Bars" 2
... 26 Nutrisystem, Inc. (Nasdaq: NTRI ), a ... announced a new multi-year alliance with the American Diabetes ... and the public about the importance of weight loss ... the relationship, Nutrisystem will support the Association,s efforts to ...
... WASHINGTON , Oct. 26 America,s ... Ignagni, President and CEO: , "A new government-run plan would underpay ... costs and improve quality. The American people want health care ... , "The divisive debate about a government-run plan is ...
... of severe physical, psychosocial suffering, researchers say , MONDAY, ... World War II, those who were potentially exposed to ... due to physical and mental stress, an Israeli study ... rates in more than 300,000 Israeli Jews who were ...
... But healthy habits can stave off the inevitable declines, research ... in fitness that accompany growing old typically speed up after ... But people can slow the inevitable by staying lean, exercising ... Oct. 26 issue of the Archives of Internal Medicine ...
... doubled risk of GERD, may be linked to mental fallout ... rescue workers can add another illness to the list of ... Zero toxins and the ensuing mental anguish of the tragedy ... shows that 41 percent of World Trade Center responders have ...
... , PLANO, Texas, Oct. 26 Perot Systems Corporation (NYSE: ... an agreement with China Telecommunications Corporation (China Telecom) in which ... information technology (IT) solutions for the healthcare industry in China. ... to develop and go to market with an e-health platform ...
Cached Medicine News:Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 2Health News:Nutrisystem and the American Diabetes Association Form a Strategic Alliance to Promote the Importance of Weight Loss for People With Type 2 Diabetes 3Health News:AHIP Statement on Government-Run Plan 2Health News:AHIP Statement on Government-Run Plan 3Health News:Exposure to Holocaust May Have Raised Cancer Risks 2Health News:Fitness Fades Fast After 45 2Health News:Fitness Fades Fast After 45 3Health News:World Trade Center Workers Have More Cases of Acid Reflux 2Health News:World Trade Center Workers Have More Cases of Acid Reflux 3Health News:Perot Systems Announces Strategic Alliance With China Telecom 2Health News:Perot Systems Announces Strategic Alliance With China Telecom 3
(Date:5/22/2013)... , May 22, 2013  Team Health Holdings ... the largest suppliers of outsourced healthcare professional staffing and ... the United States , today announced ... Annual Deutsche Bank Healthcare Conference held on May 29, ... begin at 8:00 AM eastern time.  Interested investors and ...
(Date:5/22/2013)... N.Y. , May 22, 2013  The Leukemia ... million to Valor Biotherapeutics, LLC, a joint venture ... pre-clinical development, manufacturing, and a Phase I clinical trial ... poor outcomes faced by many patients with indolent lymphomas ... Valor,s protein, IGN002, is a new ...
(Date:5/22/2013)... , May 22, 2013 The new 13-valent ... as the previous version used prior to 2010, the ... Permanente study published today in Vaccine. The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine Technology:Team Health Holdings Inc. to Present at the 38th Annual Deutsche Bank Healthcare Conference 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4
... Attend ROTH Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by ...
... 30 Phase 3 safety and efficacy data comparing tapentadol ... in patients with moderate to severe chronic osteoarthritis knee pain ... addition, this study compared oxycodone controlled release (CR) to placebo ... ER vs. Placebo The study demonstrated ...
Cached Medicine Technology:Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 2Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 3Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 4Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 5Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 6Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 2Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 3Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 4Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 5Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 6Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 7Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 8Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain 9
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... ASRs* are specifically designed for PCR ... two-color fluorescence detection systems. The NGEN ... detection of mutations associated with cystic ... well as reagents for the detection ...
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... NGEN-brand ASRs* are specifically designed for ... with two-color fluorescence detection systems. The ... the detection of mutations associated with ... as well as reagents for the ...
Medicine Products: